Key result
The updated US KDOQI guidelines recommend a haemoglobin target of 11.0-12.0 g/dl for CKD patients receiving ESAs and advise against targets >13.0 g/dl due to potential harm.
Answers are grounded in this paper and cite their sources.
This editorial discusses the implications of the updated US KDOQI Anaemia Guidelines, which recommend lower hemoglobin targets for CKD patients on ESAs based on recent trials, and suggests KDIGO should coordinate global guideline updates.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Macdougall et al. (2007) conducted an editorial in Chronic kidney disease anaemia. Erythropoiesis-stimulating agents (ESAs) targeting different haemoglobin levels was evaluated. The updated US KDOQI guidelines recommend a haemoglobin target of 11.0-12.0 g/dl for CKD patients receiving ESAs and advise against targets >13.0 g/dl due to potential harm.
Synapse has enriched 10 related papers. Consider them for comparative context: